Antimicrobial Stewardship in China: Systems, Actions and Future Strategies

Clinical Infectious Diseases

Volumn 67, Issue , 2018, Pages S135-S141

  Xiao, Yonghong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

antimicrobial resistance; antimicrobial stewardship; China; control; strategy

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANTIMICROBIAL STEWARDSHIP; CHINA; HEALTH CARE DELIVERY; HUMAN; LEGISLATION AND JURISPRUDENCE; MULTIDRUG RESISTANCE; ORGANIZATION AND MANAGEMENT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; CHINA; DELIVERY OF HEALTH CARE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 85056509113     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy641     Document Type: Article

References (31)

1. https://amr-review.org/sites/default/files/December%20report%20-%20comparative% 20deaths.jpg. Accessed 20 February 2018.
2. WHO. Global Action Plan on Antimicrobial Resistance [EB/OL].(2015-05-00)[2017-03-10]. Available at: http://www.who.int/drugresistance/global-action-plan/en/. Accessed 20 February 2018.
3. United Nations. High-level Meeting on Antimicrobial Resistance[EB/OL].(2016-09-21)[2017-3-10]. Available at: http://www.un.org/pga/71/event-latest/high-level-meeting-on-antimicrobial-resistance/. Accessed 20 February 2018.
4. Xiao YH. Regulations for clinical application of antibacterial agents-a guiding principle for the administration of antibacterial agents in medical institutions [J]. China Licensed Pharmacist 2012; 9:8-13?
5. Xiao YH?National action plan on antimicrobial resistance: a great blueprint based on One Health[J]?Chin J Clin Infect Dis 2016; 9:289-93?
6. Zhang J, Yu W, Zhao LN, et al. Epidemiology and characteristics of antibacterial resistance in China [J]. Chin J Clin Infect Dis 2016; 9:118-28.
7. Xiao Y, Wei Z, Shen P, et al. Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities. Microbes Infect 2015; 17:417-25.
8. Quan J, Li X, Jiang Y, et al. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study[J]. Lancet Infect Dis 2017; 17:400-10.
9. National Heath & Family Plan Commission of China. The administration on the clinical use of antimicrobial agents and the status quo of antimicrobial resistance in China [M]. Beijing: Peking Union Medical College Press, 2017.
10. Liu L, Cui Y, Zheng B, et al. Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach. Sci Rep 2016; 6:26930.
11. Sun Q, Tärnberg M, Zhao L, et al. Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health. PLoS One 2014; 9:e113121.
12. Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China[J]. JAMA Intern Med 2014; 174:1914-20.
13. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med 2013; 10:e1001556.
14. Available at: http://health.sohu.com/20140102/n392798756.shtml. Accessed 20 February 2018.
15. Xiao Y, Li L. The actions of China in containing antimicrobial resistance. In. AMR Control 2015.Tim Probart, 2016 UK; pp. 54-61.
16. Xiao Y, Li L. China's national plan to combat antimicrobial resistance. Lancet Infect Dis 2016; 16:1216-8.
17. Xiao Y, Li L. A national action plan to contain antimicrobial resistance in China: content, actions and expectations. In: AMR Control 2017. Tim Probart, 2017 UK; pp.17-20.
18. Ministry of Health of China. Rules for pharmaceutical affairs in healthcare institutions. Ministry of Health, 2011. Available at: http://www.moh.gov.cn/mohyzs/ s3586/201102/50581.shtml. Accessed 20 February 2018.
19. Ministry of Health of China. Administrative regulation for nosocomial infections. Ministry of Health, 2006. Available at: http://www.moh.gov.cn/mohyzs/ s3576/200804/29294.shtml. Accessed 20 February 2018.
20. Ministry of Health of China. Administrative regulations for prescription. Ministry of Health, 2007. Available at: http://www.moh.gov.cn/mohbgt/ pw10704/200804/18855.shtml. Accessed 20 February 2018.
21. Ministry of Health of China. Administrative regulations of clinical use of antibiotics. Ministry of Health, 2012. Available at: http://www.moh.gov.cn/mohyzs/ s3584/201205/54645.shtml. Accessed 20 February 2018.
22. Ministry of Health of China. The notice on establishing Ministry of Health committee of experts on rational drug use. Ministry of Health; 2012. Available at: http://www.moh.gov.cn/mohyzs/s9980/201206/0cfca0147618458585a6b83fe-194d5ad.shtml. Accessed 20 February 2018.
23. Ministry of Health of China. The notice on carrying out clinical pharmacist pilot work. Ministry of Health, 2008. Available at: http://www.moh.gov.cn/mohyzs/ s3577/200804/18775.shtml. Accessed 20 February 2018.
24. Ma XD. A study on the construction and application of antibiotics stewardship framework [D]. Wuhan, China: Huazhong University of Science and Technology, 2015.
25. Xiao YH. Introduction of Mohnarin (Ministry of Health National Antimicrobial Resistance Investigation Net). Chin J Antibiot 2008; 10:577-78
26. Ministry of Health of China. 2011 national special rectification activities program of clinical use of antibiotics (2011). Available at: http://www.moh.gov.cn/mohyzs/ s3586/201104/51376.shtml. Accessed 20 February 2018.
27. Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ; Finnish Study Group for Antimicrobial Resistance. Association between antimicrobial consumption and resistance in Escherichia coli [J]. Antimicrob Agents Chemother 2009; 53:912-7.
28. Zhang C, Li S, Ji J, Shen P, Ying C, Li L, Xiao Y. The professional status of infectious disease physicians in China: a nationwide cross-sectional survey. Clin Microbiol Infect 2018; 24:82.e5-82.e10
29. Molstad S, Cars O, Struwe J. Strama-a Swedish working model for containment of antibiotic resistance [J]. Euro Surveill 2008; 13. pii: 19041.
30. Xiao YH. Antibiotic formulary restriction: theory & practice [J]. Beijing Medical J 2012; 34:486-89.
31. Xiao YH. Infections disease physician should be the backbone of antibacterial agent rational use [J]. Int J Epidemiol Infect Dis 2009; 36:1-3.